New dialysis device for Wilson's disease tested but trial stopped early

NCT ID NCT05917327

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tested a special dialysis device (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The study planned to give 5 to 10 treatments over consecutive days and check if the device worked safely. However, the trial was stopped early after enrolling only one person, so results are very limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOLENTICULAR DEGENERATION; WILSON are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Wilson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clinic Barcelona, Liver ICU

    Barcelona, Catalonia, 08036, Spain

  • Hospital Universitario Vall d'Hebron, Unitat de Trasplantament Hepàtic Pediàtric

    Barcelona, Catalonia, 08035, Spain

  • Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie

    Lyon, Auvergne-Rhône-Alpes, 69317, France

  • Hôpital Femme Mère Enfant, Service des urgences et la réanimation pédiatriques

    Bron, Auvergne-Rhône-Alpes, 69500, France